Associated tags: Tooth decay, Conditional sentence, Enzyme, Disease, Starch, Patient, Suite, Dental, Cavitation, 2nd Floor, Radioactive decay, Dentistry, ANN, DEKRA, CFPS, Michigan State University, RCV, Medicine, MCN, U-M, Security (finance), Cryptocurrency
Retrieved on:
Wednesday, February 1, 2023
ANN,
Convention center,
Radioactive decay,
VC,
The Hub,
Hub,
Patient,
Dentistry,
Boston Convention and Exhibition Center,
Growth,
Venture capital,
Pharmaceutical industry ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- GreenMark Biomedical Inc. "GreenMark" announces its award in the competitive Startup Central Pitch event called The Hub, which the company received on Friday, Jan. 27, 2023 in Boston, Massachusetts.
Key Points:
- ANN ARBOR, Mich., Feb. 01, 2023 (GLOBE NEWSWIRE) -- GreenMark Biomedical Inc. "GreenMark" announces its award in the competitive Startup Central Pitch event called The Hub, which the company received on Friday, Jan. 27, 2023 in Boston, Massachusetts.
- After winning, Bloembergen stated, "We are thrilled to have been selected first in this competitive event with other innovation companies.
- Startup Central included GreenMark among ten company participants, and was dedicated to disruptive innovations in dentistry, as part of a three-day exhibit at the Yankee Dental Congress.
- The Startup Central exhibit and The Hub competitive startup event were sponsored by Revere Partners, the first independent Venture Capital fund exclusively dedicated to oral health.
Retrieved on:
Wednesday, January 26, 2022
Abu Dhabi Investment Office,
University Foundation,
Safety,
CSP,
BWA,
University of Michigan Business Engagement Center,
Michigan Economic Development Corporation,
Doctor of Philosophy,
Program,
Department,
University,
PE,
Conditional sentence,
Medicine,
Executive,
Tooth decay,
DEKRA,
Technology,
CFPS,
Cavitation,
Suite,
Michigan State University,
Dentistry,
Enzyme,
Disease,
Company,
RCV,
Starch,
Radioactive decay,
MCN,
Patient,
U-M,
Dental,
GLOBE,
CEO,
Association,
Security (finance),
Cryptocurrency,
Investment,
Bridge The round further includes an investment from co-inventor Dr. Brian and his wife Cheryl Clarkson, as well as company management.
Key Points:
- The round further includes an investment from co-inventor Dr. Brian and his wife Cheryl Clarkson, as well as company management.
- "Awesome that GreenMark has begun a soft launch of its LumiCare Caries Detection Rinse.
- GreenMark Biomedical Inc. has an office located at 325 E. Grand River Avenue, Suite 314, East Lansing, MI 48823, and offices & lab facilities at 1600 Huron Parkway, Building 520, Ann Arbor, MI 48109.
- About University of Michigan's MINTS: Michigan Investment in New Technology Startups is a direct investment program in the University of Michigan's endowment managed by its Investment Office.
Retrieved on:
Wednesday, September 8, 2021
Pay close attention to our winners as they are truly leading the way to provide you what is best in today's contemporary practice."
Key Points:
- Pay close attention to our winners as they are truly leading the way to provide you what is best in today's contemporary practice."
- The technology utilizes bioresorbable starch-based nanoparticles that degrade by the time the patient is ready to leave the dental office.
- "If there isn't a clear winner in a category, then we won't select one," said Dr. Chris Salierno, DDS, Cellerant Best of Class panel member.
- The 2021 Cellerant Best of Class Technology Award is selected by a panel of the most prominent technology leaders in dentistry: Dr. Paul Feuerstein, DMD, Editor in Chief for Dentistry Today;Dr. John Flucke, DDS, Technology Editor for Dental Products Report;Dr. Marty Jablow, DMD, known as America's Technology Coach;Dr. Pamela Maragliano-Muniz, DMD, Editor-in-Chief for Dental Economics;Dr. Chris Salierno, DDS, Chief Dental Officer for Tend;and Dr. Lou Shuman, DMD, CAGS, founder and creator of the Best of Class Technology Award.
EAST LANSING, Mich.and ANN ARBOR, Mich., April 8, 2021 /PRNewswire/ -- GreenMark Biomedical Inc. announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration ("FDA") to market its LumiCare Caries Detection Rinse as a 510(k) Class II Medical Device.
Key Points:
- EAST LANSING, Mich.and ANN ARBOR, Mich., April 8, 2021 /PRNewswire/ -- GreenMark Biomedical Inc. announced that the company has secured regulatory clearance from the U.S. Food and Drug Administration ("FDA") to market its LumiCare Caries Detection Rinse as a 510(k) Class II Medical Device.
- "Gaining FDA clearance for our LumiCare device at this particular time is especially gratifying given the significant pandemic challenges of the last year.
- GreenMark's LumiCare rinse enhances visualization of carious lesions (cavities and pre-cavities) by targeting and illuminating sub-surface porosities in enamel, thereby aiding in the detection of caries.
- "We recognize the impact that early-stage caries detection combined with minimally invasive preventative treatment can have for dental practices and their patients."
Retrieved on:
Wednesday, March 20, 2019
The technology utilizes bioresorbable starch-based nanoparticles which degrade into harmless materials by the time the patient is ready to leave the dental office.
Key Points:
- The technology utilizes bioresorbable starch-based nanoparticles which degrade into harmless materials by the time the patient is ready to leave the dental office.
- "Our MINTS program is pleased to join the shareholders of GreenMark Biomedical, a company with many close ties to the University of Michigan," said Rafael Castilla, director of investments.
- "These targeted diagnostic and treatment products can have major implications for dental patients by preventing cavity formation at the onset through identification and non-surgical treatment, reducing the need for invasive and costly dental procedures," said Charlie Moret, chairman and CEO, Invest Michigan.
- "GreenMark has the team and technology to improve oral health outcomes for patients," explained Patricia Glaza, SVP and managing director, Invest Detroit Ventures.
Retrieved on:
Wednesday, November 28, 2018
DETROIT, Nov. 28, 2018 /PRNewswire/ --GreenMark Biomedical Inc. today announced it was awarded the $100,000 Second Prize at the 2018 Accelerate Michigan Innovation Competition (AMIC), which includes an investment from Invest Michigan and ID Ventures as well as a $25,000 grant.
Key Points:
- DETROIT, Nov. 28, 2018 /PRNewswire/ --GreenMark Biomedical Inc. today announced it was awarded the $100,000 Second Prize at the 2018 Accelerate Michigan Innovation Competition (AMIC), which includes an investment from Invest Michigan and ID Ventures as well as a $25,000 grant.
- This grant will assist GreenMark in its development of a non-invasive treatment product aimed at preventing fully developed cavities.
- GreenMark is a minimally invasive healthcare company founded in 2016, developing technologies that involve small biopolymer particles produced from food-grade starch.
- Launched in mid-2014 through the support of the Michigan Strategic Fund, Invest Michigan has completed 92 investments in 49 companies across the state of Michigan.
